Based in Abingdon (UK) and Philadelphia (USA) we're a privately owned, world leading soluble T Cell Receptor (TCR) biotechnology company, that is focused on delivering first-in-class biological therapies that have the potential to transform the lives of people with serious diseases.
Our primary therapeutic focus is oncology, and we also...